Metronidazole and amebiasis.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002353:Carrier State / Q000188:drug therapy*; D004404:Dysentery, Amebic / Q000188:drug therapy*; D004748:Entamoeba histolytica / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005260:Female; D005334:Fever / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D008101:Liver Abscess, Amebic / Q000188:drug therapy*; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011247:Pregnancy; D012007:Rectum / Q000382:microbiology; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors
D008795:Metronidazole